iifl-logo-icon 1
iifl-logo-icon 1

Carol Info Services Ltd Share Price

₹162
(0.00%)
Mar 9, 2012|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Carol Info Services Ltd KEY RATIOS

Sector

Miscellaneous

Open

₹161.65

Prev. Close

₹162

Turnover(Lac.)

₹22.57

Day's High

₹162.45

Day's Low

₹161.65

52 Week's High

₹0

52 Week's Low

₹0

Book Value

₹318.92

Face Value

₹10

Mkt Cap (₹ Cr.)

574.07

P/E

15.01

EPS

10.79

Divi. Yield

0

Carol Info Services Ltd Corporate Action

No Record Found

Carol Info Services Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Carol Info Services Ltd SHAREHOLDING SNAPSHOT

05 Oct, 2024|09:37 AM
Dec-2011Sep-2011Jun-2011Mar-2011
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 63.73%

Foreign: 0.00%

Indian: 63.73%

Non-Promoter- 0.40%

Institutions: 0.40%

Non-Institutions: 35.46%

Custodian: 0.39%

Read More
Share Price

Carol Info Services Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

35.44

35.44

35.44

35.44

Preference Capital

0

0

0

0

Reserves

1,094.7

1,052.89

976.78

909.05

Net Worth

1,130.14

1,088.33

1,012.22

944.49

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2019Mar-2018Mar-2017Mar-2016

Revenue

71.27

67.01

65.53

61.77

yoy growth (%)

6.36

2.25

6.08

11.85

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-0.08

-0.07

-0.08

-0.15

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2019Mar-2018Mar-2017Mar-2016

Profit before tax

95.23

93.84

115.43

100.47

Depreciation

-2.38

-2.22

-2.38

-3.29

Tax paid

-33.24

-26.72

-35.56

-27.25

Working capital

184.02

115.71

14.65

-26.51

Other operating items

View Cash Flow
Y/e 31 MarMar-2019Mar-2018Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

6.36

2.25

6.08

11.85

Op profit growth

-11.19

-42.77

5.33

8.68

EBIT growth

1.31

-15.77

9.83

124.15

Net profit growth

-7.63

-15.97

9.1

222.15

View Ratios
Particulars (Rupees in Crores.)Dec-2002Dec-2001

Gross Sales

188

246.5

Excise Duty

0

0

Net Sales

188

246.5

Other Operating Income

0

0

Other Income

157.6

4

View Annually Results

Carol Info Services Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

GMR Airports Infrastructure Ltd

GMRINFRA

89.94

093,658.12-145.660202.3450.25

Rites Ltd

RITES

317.25

36.4615,420.1764.862.81453.7852.16

Godrej Agrovet Ltd

GODREJAGRO

739.9

35.1714,328.28136.391.341,734.14117.5

RattanIndia Enterprises Ltd

RTNINDIA

73.16

8.5810,163.83863.0902.576.84

CMS Info Systems Ltd

CMSINFO

593.1

26.499,557.6481.870.98552.53115.79

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Carol Info Services Ltd

Management

Register Office

Registrar Office

Managing Director & CFO

Stephen D Souza

Chairman & Independent Directo

Akhtar Shamsi

Independent Director

Vijaya Nair

Company Sec. & Compli. Officer

Alwin Lopes

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by Carol Info Services Ltd

Summary

Wockhardt was promoted by the Khorakiwala family in 1959 and was known as Worli Chemicals. In 1979, Wockhardt set up a new pharmaceutical plant at Aurangabad. A second company, Wockhardt Synchem, was floated to manufacture speciality bulk drugs, at Ankleshwar, Gujarat.With the demerger of its pharmaceutical division into a separate entity, the company has been renamed Wockhardt Life Science while the new company with the pharmaceutical division is now called Wockhardt. In 1989, it diversified into medical services by setting up a day-care facility, Wockhardt Medical and Research Centre at Calcutta. In 1990, Wockhardt set up an IV fluid manufacturing plant at Waluj with technical assistance from Pharmaplan, Germany. It also started a super-speciality hospital in Bangalore, specialising in cardiology, cardiac surgery and kidney transplants. In 1992, it commissioned its new bulk drugs plant and began work on its third bulk drug plant at Ankleshwar. It set up a subsidiary in Ireland, Wockhardt Europe, to promote exports. In 1994, Wockhardt floated a $ 75 mln GDR issue to raise the funds required for its expansion plans.It has enterered into a joint venture with Rhein Biotech, Germany, for research and development and manufacturing of biotechnology products. In 1995, Wockhardt received the national award for R&D efforts in the biotech industries by the Department of Science and Industrial Research. It has acquired Accumed Pharmaceuticals, US, with which it had a joint venture for
Read More

QUICKLINKS FOR Carol Info Services Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Loans
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp